Edition:
United Kingdom

People: NOVA Group Holdings Ltd (1360.HK)

1360.HK on Hong Kong Stock

2.01HKD
8:59am BST
Change (% chg)

HK$-0.01 (-0.50%)
Prev Close
HK$2.02
Open
HK$2.01
Day's High
HK$2.03
Day's Low
HK$1.99
Volume
2,320,000
Avg. Vol
14,960,674
52-wk High
HK$4.46
52-wk Low
HK$1.60

Qiu, Peiyuan 

Mr. Qiu Peiyuan is Non-Executive Independent Director of the Company. He graduated from the Biology Department, Nankai University with a bachelor of science degree in biology in 1986, from the Faculty of Science, The University of Hong Kong with a master’s degree in bioscience in 1998, and from the Business School of the University of Western Ontario, Canada with a master’s degree in business administration in 2003. Following his graduation, Mr. Qiu joined the Bank of Nova Scotia as a senior analyst. Mr. Qiu joined the T. Rowe Price Group in 2008 as vice president, Asia. Mr. Qiu joined Huabao Trust Co., Ltd. in 2011 as general manager of the international business department. Mr. Qiu joined Ping An Trust Co., Ltd. in 2015 as president of overseas investment department and senior managing director, responsible for establishing overseas investment department and determining its overseas investment strategies and plans. Mr. Qiu has obtained chartered financial analyst (CFA), Canadian certificated financial planner (CFP), Canadian fund company partner, director and senior management, and Canadian securities qualifications. He has been a non-executive director of China Health Group Limited (stock code: 673) since 4 June 2018.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --